Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...
ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare ...
MBC BioLabs sees its two biotech incubators location in San Francisco's Dogpatch neighborhood, near the AI hub of Mission Bay, as an advantage. It wants to build one more to prove the point.
Humacyte is cutting about a quarter of its workforce as it revamps its commercial strategy. Durham biotech's breakthrough ...
CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...
Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs ...
Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Following a robust rally, Moderna appears to be regaining leadership within the biotech space. This ...
Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...
In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to ...
Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...
Legend Biotech Corp LEGN reported downbeat results for the first quarter on Tuesday. The company posted quarterly losses of 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results